Your browser doesn't support javascript.
loading
Aurora A kinase as a target for therapy in TCF3-HLF rearranged acute lymphoblastic leukemia.
Leonard, Jessica; Wolf, Joelle Sj; Degnin, Michelle; Eide, Christopher A; LaTocha, Dorian; Lenz, Kyle; Wilmot, Beth; Mullighan, Charles G; Loh, Mignon; Hunger, Stephen P; Druker, Brian J; Loriaux, Marc M; Tyner, Jeffrey W; Chang, Bill H.
Afiliação
  • Leonard J; Division of Hematology and Medical Oncology, Department of Medicine and OHSU Knight Cancer Institute. OHSU, Portland, Oregon.
  • Wolf JS; Division of Hematology and Oncology, Department of Pediatrics and OHSU Knight Cancer Institute. OHSU, Portland, Oregon.
  • Degnin M; Division of Hematology and Medical Oncology, Department of Medicine and OHSU Knight Cancer Institute. OHSU, Portland, Oregon.
  • Eide CA; Division of Hematology and Medical Oncology, Department of Medicine and OHSU Knight Cancer Institute. OHSU, Portland, Oregon.
  • LaTocha D; Division of Hematology and Medical Oncology, Department of Medicine and OHSU Knight Cancer Institute. OHSU, Portland, Oregon.
  • Lenz K; Division of Hematology and Oncology, Department of Pediatrics and OHSU Knight Cancer Institute. OHSU, Portland, Oregon.
  • Wilmot B; Division of Bioinformatics and Computational Biology, Department of Medical Informatics and Clinical Epidemiology, and OHSU Knight Cancer Institute, OHSU, Portland, Oregon.
  • Mullighan CG; Department of Pathology, St Jude Children's Research Hospital and University of Tennessee Health Science Center, Memphis, TN 38105.
  • Loh M; Department of Pediatrics, Benioff Children's Hospital, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, California.
  • Hunger SP; Department of Pediatrics and the Center for Childhood Cancer Research, Children's Hospital of Philadelphia and the Perelman School of Medicine at the University of Pennsylvania, Children's Hospital of Philadelphia.
  • Druker BJ; Division of Hematology and Medical Oncology, Department of Medicine and OHSU Knight Cancer Institute. OHSU, Portland, Oregon, USA; Investigator, Howard Hughes Medical Institute.
  • Loriaux MM; Department of Pathology and OHSU Knight Cancer Institute. OHSU, Portland, Oregon.
  • Tyner JW; Division of Hematology and Medical Oncology, Department of Medicine and OHSU Knight Cancer Institute. OHSU, Portland, Oregon, USA; Department of Cell, Molecular, and Cancer Biology, and OHSU Knight Cancer Institute, OHSU, Portland, Oregon.
  • Chang BH; Division of Hematology and Oncology, Department of Pediatrics and OHSU Knight Cancer Institute. OHSU, Portland, Oregon.
Haematologica ; 106(11): 2990-2994, 2021 11 01.
Article em En | MEDLINE | ID: mdl-34233449
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia-Linfoma Linfoblástico de Células Precursoras / Aurora Quinase A Limite: Humans Idioma: En Revista: Haematologica Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia-Linfoma Linfoblástico de Células Precursoras / Aurora Quinase A Limite: Humans Idioma: En Revista: Haematologica Ano de publicação: 2021 Tipo de documento: Article